Our latest publication demonstrated that high expression of EP3 is associated with poor prognosis in overall survival rates of cervical cancer patients in both squamous cell carcinoma and adenocarcinoma (Heidegger et al. 2017). The gene discussed is PTGER3; the disease is cervical cancer.